Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
1.019
-0.052 (-4.81%)
Jan 28, 2026, 10:59 AM EST - Market open
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $32.65 million as of January 28, 2026. Its market cap has decreased by -61.13% in one year.
Market Cap
32.65M
Enterprise Value
-688.98K
1-Year Change
-61.13%
Ranking
Category
Stock Price
$1.02
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $32.65M, a decrease of -90.83%. That is a compound annual growth rate of -73.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 34.30M | 42.92% |
| Dec 31, 2025 | 24.00M | -72.06% |
| Dec 31, 2024 | 85.90M | -75.88% |
| Apr 11, 2024 | 356.10M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Marker Therapeutics | 35.01M |
| Cue Biopharma | 34.67M |
| Evaxion | 33.69M |
| Pluri | 33.13M |
| Werewolf Therapeutics | 32.75M |
| Dyadic International | 32.57M |
| Outlook Therapeutics | 32.25M |
| AN2 Therapeutics | 32.06M |